S. Evans

First name
S.
Middle name
J.
Last name
Evans
Douglas, I. J., Evans, S. J., Pocock, S., & Smeeth, L. (2009). The risk of fractures associated with thiazolidinediones: a self-controlled case-series study. PLoS Med. http://doi.org/10.1371/journal.pmed.1000154
McDowell, S. E., Coleman, J. J., Evans, S. J., Gill, P. S., & Ferner, R. E. (2010). Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1935
Coleman, J. J., McDowell, S. E., Evans, S. J., Gill, P. S., & Ferner, R. E. (2010). Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2010.03654.x
Douglas, I. J., Evans, S. J., Hingorani, A. D., Grosso, A. M., Timmis, A., Hemingway, H., & Smeeth, L. (2012). Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs. Bmj. http://doi.org/10.1136/bmj.e4388
Evans, S. J., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013). Prevalence of adult Huntington\textquoterights disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry. http://doi.org/10.1136/jnnp-2012-304636
Goh, K. L., Bhaskaran, K., Minassian, C., Evans, S. J., Smeeth, L., & Douglas, I. J. (2015). Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12511
Wexler, N. S., Collett, L., Wexler, A. R., Rawlins, M. D., Tabrizi, S. J., Douglas, I., et al. (2016). Incidence of adult Huntington\textquoterights disease in the UK: a UK-based primary care study and a systematic review. BMJ Open. http://doi.org/10.1136/bmjopen-2015-009070
Beau-Lejdstrom, R., Douglas, I., Evans, S. J., & Smeeth, L. (2016). Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open. http://doi.org/10.1136/bmjopen-2015-010508
Root, A. A., . Y. Wong, A., Ghebremichael-Weldeselassie, Y., Smeeth, L., Bhaskaran, K., Evans, S. J., et al. (2016). Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12983
Brown, J. P., Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., et al. (2021). Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14728